• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸十四烷五钒酸盐对 Na/K-和 Ca-ATPase 活性的抑制作用。

Inhibition of Na/K- and Ca-ATPase activities by phosphotetradecavanadate.

机构信息

ISE, University of Algarve, 8005-139 Faro, Portugal; CCMar, University of Algarve, 8005-139 Faro, Portugal.

CCMar, University of Algarve, 8005-139 Faro, Portugal.

出版信息

J Inorg Biochem. 2019 Aug;197:110700. doi: 10.1016/j.jinorgbio.2019.110700. Epub 2019 Apr 29.

DOI:10.1016/j.jinorgbio.2019.110700
PMID:31075720
Abstract

Polyoxometalates (POMs) are promising inorganic inhibitors for P-type ATPases. The experimental models used to study the effects of POMs on these ATPases are usually in vitro models using vesicles from several membrane sources. Very recently, some polyoxotungstates, such as the Dawson anion [PWO], were shown to be potent P-type ATPase inhibitors; being active in vitro as well as in ex-vivo. In the present study we broaden the spectrum of highly active inhibitors of Na/K-ATPase from basal membrane of epithelial skin to the bi-capped Keggin-type anion phosphotetradecavanadate CsHPVO (PV) and we confront the data with activity of other commonly encountered polyoxovanadates, decavanadate (V) and monovanadate (V). The X-ray crystal structure of PV was solved and contains two trans-bicapped α-Keggin anions HPVO. The anion is built up from the classical Keggin structure [(PO)@(VO)] capped by two [VO] units. PV (10 μM) exhibited higher ex-vivo inhibitory effect on Na/K-ATPase (78%) than was observed at the same concentrations of V (66%) or V (33%). Moreover, PV is also a potent in vitro inhibitor of the Ca-ATPase activity (IC 5 μM) exhibiting stronger inhibition than the previously reported activities for V (15 μM) and V (80 μM). Putting it all together, when compared both P-typye ATPases it is suggested that PV exibited a high potential to act as an in vivo inhibitor of the Na/K-ATPase associated with chloride secretion.

摘要

多金属氧酸盐(POMs)是一类有前途的无机 P 型 ATP 酶抑制剂。用于研究 POMs 对这些 ATP 酶影响的实验模型通常是使用来自几种膜源的囊泡的体外模型。最近,一些多钨酸盐,如 Dawson 阴离子[PWO],被证明是有效的 P 型 ATP 酶抑制剂;在体外和体内都具有活性。在本研究中,我们将高度活跃的上皮皮肤基底膜 Na/K-ATP 酶抑制剂的范围从基础膜拓宽到双帽 Keggin 型阴离子磷十四钒酸盐 CsHPVO(PV),并将数据与其他常见的多钒酸盐、十钒酸盐(V)和一钒酸盐(V)的活性进行对比。PV 的 X 射线晶体结构已被解决,其中包含两个反式双帽 α-Keggin 阴离子 HPVO。该阴离子由经典的 Keggin 结构[(PO)@(VO)]构成,由两个[VO]单元封端。PV(10 μM)在离体条件下对 Na/K-ATP 酶的抑制作用(78%)高于相同浓度下的 V(66%)或 V(33%)。此外,PV 也是一种有效的 Ca-ATPase 活性的体外抑制剂(IC 5 μM),其抑制作用强于先前报道的 V(15 μM)和 V(80 μM)的活性。综上所述,当与两种 P 型 ATP 酶进行比较时,建议 PV 具有作为与氯分泌相关的 Na/K-ATP 酶体内抑制剂的高潜力。

相似文献

1
Inhibition of Na/K- and Ca-ATPase activities by phosphotetradecavanadate.磷酸十四烷五钒酸盐对 Na/K-和 Ca-ATPase 活性的抑制作用。
J Inorg Biochem. 2019 Aug;197:110700. doi: 10.1016/j.jinorgbio.2019.110700. Epub 2019 Apr 29.
2
The P-type ATPase inhibiting potential of polyoxotungstates.多酸型 P 型 ATP 酶抑制剂的潜力。
Metallomics. 2018 Feb 21;10(2):287-295. doi: 10.1039/c7mt00279c.
3
Influence of decavanadate on rat synaptic plasma membrane ATPases activity.十钒酸盐对大鼠突触质膜ATP酶活性的影响。
Gen Physiol Biophys. 2009 Sep;28(3):302-8. doi: 10.4149/gpb_2009_03_302.
4
Synthesis, crystal structure, computational and solution studies of a new phosphotetradecavanadate salt. Assessment of its effect on U87 glioblastoma cells.一种新型十四钒磷酸盐的合成、晶体结构、计算及溶液研究。评估其对U87胶质母细胞瘤细胞的作用。
J Inorg Biochem. 2025 Aug;269:112882. doi: 10.1016/j.jinorgbio.2025.112882. Epub 2025 Mar 9.
5
Sarcoplasmic reticulum calcium ATPase interactions with decaniobate, decavanadate, vanadate, tungstate and molybdate.肌浆网钙 ATP 酶与癸硼酸、十钒酸、钒酸盐、钨酸盐和钼酸盐的相互作用。
J Inorg Biochem. 2012 Feb;107(1):82-9. doi: 10.1016/j.jinorgbio.2011.10.010. Epub 2011 Oct 29.
6
Comparison between plasma membrane Ca2+ and Na,K-ATPases: short review.质膜钙泵与钠钾ATP酶的比较:简要综述
Braz J Med Biol Res. 1988;21(6):1261-7.
7
Adenosine triphosphatases of rat pancreatic islets: comparison with those of rat kidney.大鼠胰岛的三磷酸腺苷酶:与大鼠肾脏的三磷酸腺苷酶比较。
J Clin Invest. 1978 Sep;62(3):692-701. doi: 10.1172/JCI109177.
8
Binding domain of oligomycin on Na(+),K(+)-ATPase.寡霉素在钠钾ATP酶上的结合结构域。
Eur J Pharmacol. 2000 Jul 21;400(2-3):177-83. doi: 10.1016/s0014-2999(00)00411-8.
9
Inhibition of rat synaptic membrane Na⁺/K⁺-ATPase and ecto-nucleoside triphosphate diphosphohydrolases by 12-tungstosilicic and 12-tungstophosphoric acid.钨硅酸和钨磷酸对大鼠突触膜 Na⁺/K⁺-ATP 酶和核苷酸三磷酸二磷酸水解酶的抑制作用。
Bioorg Med Chem. 2011 Dec 1;19(23):7063-9. doi: 10.1016/j.bmc.2011.10.008. Epub 2011 Oct 13.
10
Prolactin directly enhanced Na+/K+- and Ca2+-ATPase activities in the duodenum of female rats.催乳素直接增强了雌性大鼠十二指肠中钠钾ATP酶和钙ATP酶的活性。
Can J Physiol Pharmacol. 2006 May;84(5):555-63. doi: 10.1139/y05-161.

引用本文的文献

1
Molecular Basis of Na, K-ATPase Regulation of Diseases: Hormone and FXYD2 Interactions.钠钾ATP酶疾病调节的分子基础:激素与FXYD2的相互作用
Int J Mol Sci. 2024 Dec 13;25(24):13398. doi: 10.3390/ijms252413398.
2
Repurposing Therapeutic Drugs Complexed to Vanadium in Cancer.癌症中钒复合治疗药物的重新利用
Pharmaceuticals (Basel). 2023 Dec 21;17(1):12. doi: 10.3390/ph17010012.
3
Polyoxidovanadates a new therapeutic alternative for neurodegenerative and aging diseases.多氧化钒酸盐:神经退行性疾病和衰老疾病的一种新的治疗选择。
Neural Regen Res. 2024 Mar;19(3):571-577. doi: 10.4103/1673-5374.380877.
4
Biological Consequences of Vanadium Effects on Formation of Reactive Oxygen Species and Lipid Peroxidation.钒对活性氧形成和脂质过氧化的生物学影响。
Int J Mol Sci. 2023 Mar 11;24(6):5382. doi: 10.3390/ijms24065382.
5
Polyoxometalates Impact as Anticancer Agents.多酸作为抗癌剂的作用。
Int J Mol Sci. 2023 Mar 6;24(5):5043. doi: 10.3390/ijms24055043.
6
Editorial: Emerging polyoxometalates with biological, biomedical, and health applications.社论:具有生物、生物医学及健康应用的新型多金属氧酸盐
Front Chem. 2022 Aug 9;10:977317. doi: 10.3389/fchem.2022.977317. eCollection 2022.
7
Polyoxovanadates as new P-glycoprotein inhibitors: insights into the mechanism of inhibition.多氧钒酸盐作为新型P-糖蛋白抑制剂:对抑制机制的见解
FEBS Lett. 2022 Feb;596(3):381-399. doi: 10.1002/1873-3468.14265. Epub 2021 Dec 30.
8
Rationalizing the Decavanadate(V) and Oxidovanadium(IV) Binding to G-Actin and the Competition with Decaniobate(V) and ATP.合理化十钒酸盐(V)和氧化钒(IV)与 G-肌动蛋白的结合以及与十铌酸盐(V)和 ATP 的竞争。
Inorg Chem. 2021 Jan 4;60(1):334-344. doi: 10.1021/acs.inorgchem.0c02971. Epub 2020 Nov 30.
9
Cation-Directed Synthetic Strategy Using 4f Tungstoantimonates as Nonlacunary Precursors for the Generation of 3d-4f Clusters.以4f钨锑酸盐为非缺位前驱体生成3d-4f簇合物的阳离子导向合成策略
Inorg Chem. 2020 Jun 15;59(12):8461-8467. doi: 10.1021/acs.inorgchem.0c00890. Epub 2020 May 22.
10
The Aquaporin-3-Inhibiting Potential of Polyoxotungstates.多酸化合物抑制水通道蛋白 3 的潜力。
Int J Mol Sci. 2020 Apr 2;21(7):2467. doi: 10.3390/ijms21072467.